Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03324373
Title Lenvatinib and Everolimus in Renal Cell Carcinoma (RCC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Yousef Zakharia
Indications

renal cell carcinoma

Therapies

Everolimus + Lenvatinib

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Iowa Hospitals and Clinics Recruiting Iowa City Iowa 52242 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field